I can only speak for myself when I say that I didn’t have in mind MYDX being attacked by a premeditated collusion scheme when I bought in March 2017 after it broke .01. Why risk having what happened in March 2017 only lead back to where we are without legal precedence?
I Still Think MYDX Will.Trade.At.$.05-$.10.In.2018.... It'll.be.the.bottom.of.the.range,and it may be the last day of the year but I think its still likely. We need to see new products and/or services generate revenue for the company. SmartPen will be out in Q3. SmartLabel in theory is already out. CannaDx will continue to generate revenue and I'd love to see them lower the price to capture the $300-$499 group of buyers. Medical Device Approval in Canada will help. Positive progress on the clinical trials will help. Revenue from services, analytics, software and partnerships will all add to revenue generation. MYDX SP in Q3 and Q4 should easily get into pennyland.
News 
Market Data 
Discover 
